Teladoc Health, Inc. (NYSE:TDOC – Free Report) – Investment analysts at Zacks Research issued their FY2027 earnings per share estimates for Teladoc Health in a report released on Wednesday, March 12th. Zacks Research analyst R. Department expects that the health services provider will earn ($0.71) per share for the year. The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share.
Other equities research analysts have also recently issued research reports about the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Piper Sandler decreased their target price on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Royal Bank of Canada raised their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. The Goldman Sachs Group decreased their target price on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, March 3rd. Finally, Oppenheimer decreased their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Eleven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $11.26.
Teladoc Health Trading Up 1.6 %
Shares of TDOC stock opened at $8.63 on Friday. The stock has a 50-day moving average of $10.58 and a 200-day moving average of $9.67. Teladoc Health has a 1-year low of $6.76 and a 1-year high of $15.68. The stock has a market cap of $1.50 billion, a price-to-earnings ratio of -1.49 and a beta of 1.27. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.
Teladoc Health (NYSE:TDOC – Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after purchasing an additional 1,029,829 shares in the last quarter. Point72 Asset Management L.P. lifted its holdings in shares of Teladoc Health by 33.6% in the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock valued at $101,625,000 after purchasing an additional 2,813,568 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Teladoc Health by 15.5% in the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider’s stock valued at $51,582,000 after purchasing an additional 763,265 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Teladoc Health by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock valued at $35,894,000 after purchasing an additional 22,664 shares in the last quarter. Finally, Maple Rock Capital Partners Inc. lifted its holdings in Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after acquiring an additional 2,331,000 shares during the period. Institutional investors own 76.82% of the company’s stock.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
See Also
- Five stocks we like better than Teladoc Health
- Why Invest in 5G? How to Invest in 5G Stocks
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- The 3 Best Fintech Stocks to Buy Now
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.